Jorge A. Soto

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · Clinical Infectious Diseases · 2021 · 109 citations · Full text

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

Felipe Melo-González, Jorge A. Soto, Liliana A González et al. · Frontiers in Immunology · 2021 · 80 citations · Full text

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga et al. · Frontiers in Immunology · 2021 · 67 citations · Full text

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · 2021 · 59 citations · Full text

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

Katia Abarca, Emma Rey-Jurado, Natalia Muñoz‐Durango et al. · EClinicalMedicine · 2020 · 54 citations · Full text